Filed Pursuant to Rule 424(b)(5)
Registration Statement No. 333-277185
PROSPECTUS SUPPLEMENT
(To prospectus dated February 20, 2024)
$1,000,000,000
Ventas, Inc.
Common Stock
On February 20, 2024, we entered into Amendment No. 1 (the “Amendment”) to our ATM Sales Agreement, dated November 8, 2021 (as may be amended from time to time, the “Sales Agreement”), with BofA Securities, Inc., BNP Paribas Securities Corp., Citigroup Global Markets Inc., Credit Agricole Securities (USA) Inc., Jefferies LLC, J.P. Morgan Securities LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., RBC Capital Markets, LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC, UBS Securities LLC, Wells Fargo Securities, LLC and certain of their respective affiliates (each, a “Sales Agent,” and collectively, the “Sales Agents”), and the Forward Purchasers (as defined below) relating to the shares of our common stock offered by this prospectus supplement. We refer to a Sales Agent, when acting as sales agent for the relevant Forward Purchaser, as individually, a “Forward Seller,” and collectively, the “Forward Sellers.” The Amendment increased the aggregate gross sales price of common stock available for issuance under the Sales Agreement to $1,000,000,000.
Offers and sales, if any, of the shares of our common stock offered by this prospectus supplement made through the Sales Agents, as our sales agents or as Forward Sellers, may be made by means of ordinary brokers’ transactions on the New York Stock Exchange (the “NYSE”), through a market maker or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices, by privately negotiated transactions (including block sales) or by any other methods permitted by applicable law. The Sales Agreement contemplates that, in addition to the issuance and sale by us of shares of our common stock to or through the Sales Agents, we may enter into separate forward sale agreements (each, a “forward sale agreement,” and collectively, the “forward sale agreements”), each with Bank of America, N.A., BNP Paribas, Citibank, N.A., Crédit Agricole Corporate and Investment Bank, Jefferies LLC, JPMorgan Chase Bank, National Association, Mizuho Markets Americas LLC, Morgan Stanley & Co. LLC, MUFG Securities EMEA plc, Royal Bank of Canada, The Bank of Nova Scotia, The Toronto-Dominion Bank, UBS AG London Branch and Wells Fargo Bank, National Association and certain of their respective affiliates. When acting in their capacity as purchasers under any forward sale agreements, we refer to these entities individually as a “Forward Purchaser,” and collectively, as the “Forward Purchasers.” If we enter into a forward sale agreement with any Forward Purchaser, we expect that such Forward Purchaser or its affiliate may attempt to borrow from third parties and sell, through the relevant Forward Seller, shares of our common stock to hedge such Forward Purchaser’s exposure under such forward sale agreement. Unless otherwise expressly stated or the context otherwise requires, references herein to the “related” or “relevant” Forward Purchaser mean, with respect to any Forward Seller, the affiliate of such Forward Seller that is acting as Forward Purchaser or, if applicable, such Forward Seller acting in its capacity as Forward Purchaser, and references herein to “applicable” Forward Purchaser or “applicable” forward sale agreements mean, with respect to any Forward Purchaser and any forward sale agreement, the Forward Purchaser party to such forward sale agreement, as applicable. Only Forward Sellers that are, or are affiliated with, Forward Purchasers will act as Forward Sellers. We will not initially receive any proceeds from any sale of shares of our common stock borrowed by a Forward Purchaser or its affiliate and sold through the related Forward Seller.
We currently expect to fully physically settle each forward sale agreement, if any, with the relevant Forward Purchaser on one or more dates specified by us on or prior to the maturity date of such forward sale agreement, in which case we expect to receive aggregate net cash proceeds at settlement equal to the number of shares specified in such forward sale agreement multiplied by the relevant forward price per share. However, subject to certain exceptions, we may also elect, in our sole discretion, to cash settle or net share settle all or any portion of our obligations under any forward sale agreement, in which case we may not receive any proceeds (in the case of cash settlement) or will not receive any proceeds (in the case of net share settlement), and we may owe cash (in the case of cash settlement) or shares of our common stock (in the case of net share settlement) to the relevant Forward Purchaser. See “Plan of Distribution” in this prospectus supplement.
None of the Sales Agents, whether acting as our sales agent or Forward Seller, is required to sell any specific number or dollar amount of shares of our common stock, but each has agreed, subject to the terms and conditions of the Sales Agreement, to use its commercially reasonable efforts, consistent with its normal trading and sales practices and applicable law and regulations, to sell shares of our common stock on terms agreed upon by such Sales Agent, us and, in the case of shares offered through such Sales Agent as Forward Seller, the relevant Forward Purchaser from time to time. The Sales Agreement provides that the shares of our common stock offered and sold through the Sales Agents, as our sales agents or as Forward Sellers, pursuant to the Sales Agreement will be offered and sold through only one Sales Agent on any trading day.
We will pay the applicable Sales Agent a commission that will not exceed, but may be lower than, 2.0% of the gross sales price of the shares of our common stock sold through such Sales Agent, as our sales agent. In connection with each forward sale agreement, we will pay the applicable Sales Agent, acting as Forward Seller in connection with such forward sale agreement, a commission, in the form of a reduction to the initial forward price under the related forward sale agreement, that will not exceed, but may be lower than, 2.0% of the gross sales price of the borrowed shares of our common stock sold through such Sales Agent, as Forward Seller, during the applicable forward selling period for such shares (subject to certain possible adjustments to such gross sales price for daily accruals and any quarterly dividends having an “ex-dividend” date during such forward selling period). We may also agree with any Sales Agent, whether acting as our sales agent or as Forward Seller, to sell shares of our common stock other than through ordinary brokers’ transactions on the NYSE, and for which we may agree to pay such Sales Agent a commission that is customary for such sales.
Under the terms of the Sales Agreement, we may also sell shares of our common stock to one or more of the Sales Agents as principal, at a price per share to be agreed upon at the time of sale. If we sell shares to one or more of the Sales Agents as principal, we will enter into a separate terms agreement with such Sales Agent or Sales Agents, as the case may be, and we will describe the terms of the offering of those shares in a separate prospectus supplement.
As of the date of this prospectus supplement, we have sold shares of common stock having an aggregate gross sales price of $110,400,000 under the Sales Agreement and the forward sale agreements, and shares of common stock having an aggregate gross sales price of $889,600,000 were not sold. The Amendment increased the aggregate gross sales price of common stock we may offer and sell pursuant to the Sales Agreement by $110,400,000 to $1,000,000,000. This prospectus supplement, together with the accompanying prospectus, supersedes the prospectus supplement dated November 8, 2021.
Our common stock is listed on the NYSE under the symbol “VTR.” On February 16, 2024, the last reported sale price for our common stock as reported on the NYSE was $43.76 per share.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
| BofA Securities | | | BNP PARIBAS | | | Citigroup | |
| Credit Agricole CIB | | | Jefferies | | | J.P. Morgan | |
| Mizuho | | | Morgan Stanley | | | MUFG | |
| RBC Capital Markets | | | Scotiabank | | | TD Securities | |
| UBS Investment Bank | | | | | | Wells Fargo Securities | |
The date of this prospectus supplement is February 20, 2024.